Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000030

Options or other derivatives

  • Chief Scientific Officer acquired 212,950 shares (grant or award)
  • Chief Scientific Officer returned 212,950 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Fisher Stewart · Chief Scientific Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-03-07 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −94,950 0 D
2024-03-07 Grant or award : show line 2 in the form Stock Option (Right to Buy) +94,950 94,950 D
2024-03-07 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −118,000 0 D
2024-03-07 Grant or award : show line 4 in the form Stock Option (Right to Buy) +118,000 118,000 D
Loading xslF345X05/wk-form4_1709943962.xml…